In this setting, aKIR+ NK cells from donors lacking expression of ligands for the aKIRs could potentially recognize the recipients’ leukemia blasts, e.g., when transplanting a HLA-C2 positive recipient with cells from a KIR2DS1 positive but HLA-C2 negative donor. Here, C2 is linked to leukemia.